3 results
Approved WMORecruiting
To compare the efficacy of six cycles neoadjuvant PTC plus pertuzumab preceded by either three cycles of FEC-T plus pertuzumab or three cycles of PTC plus pertuzumab in HER2 positive breast cancerSecondary objectives• To describe the safety of the…
Approved WMORecruiting
Primary Objective:To establish the maximum tolerated healthy liver-absorbed dose of 166Ho-microspheres in patients with HCC who receive RL as a bridge to resection.Secondary Objective(s): 1) To establish dose-response relationships between:a. The…
Approved WMORecruiting
The purpose of this study is to develop a new investigational procedure for diagnosing Barrett*s Esophagus (BE) and Esophageal Adenocarcinoma (EAC).